rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1999-5-10
|
pubmed:abstractText |
Ischemic colitis develops after a sudden decrease in colonic blood supply and has a variety of clinical manifestations. The aim of this study was to assess the role of platelet activating factor in the pathogenesis of ischemic colitis with use of the platelet activating factor antagonist TCV-309.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0012-3706
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
218-24
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10211499-Animals,
pubmed-meshheading:10211499-Colitis, Ischemic,
pubmed-meshheading:10211499-Colon,
pubmed-meshheading:10211499-Intestinal Mucosa,
pubmed-meshheading:10211499-Isoquinolines,
pubmed-meshheading:10211499-Male,
pubmed-meshheading:10211499-Platelet Activating Factor,
pubmed-meshheading:10211499-Platelet Aggregation Inhibitors,
pubmed-meshheading:10211499-Pyridinium Compounds,
pubmed-meshheading:10211499-Random Allocation,
pubmed-meshheading:10211499-Rats,
pubmed-meshheading:10211499-Rats, Wistar,
pubmed-meshheading:10211499-Tetrahydroisoquinolines,
pubmed-meshheading:10211499-Thiobarbiturates
|
pubmed:year |
1999
|
pubmed:articleTitle |
Role of platelet activating factor on severity of ischemic colitis.
|
pubmed:affiliation |
First Department of Surgery, Kobe University School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|